» Articles » PMID: 16493039

The Dual-specific Binding of Dengue Virus and Target Cells for the Antibody-dependent Enhancement of Dengue Virus Infection

Overview
Journal J Immunol
Date 2006 Feb 24
PMID 16493039
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Using flow cytometric assay and monoclonal anti-dengue Ab, we observed that both anti-E and anti-prM Abs could enhance dengue virus infection in a concentration-dependent but serotype-independent manner. Increases were found in both the percentage of dengue-infected cells and the expression of dengue E and NS1 protein per cell. Dengue virion binding and infection were enhanced on FcR-bearing cells via the Fc-FcgammaRII pathway. Furthermore, anti-prM Ab also enhanced dengue virion binding and infection on cells lacking FcR, such as BHK-21 or A549 cells, by the mechanism of peptide (CPFLKQNEPEDIDCW)-specific binding. Anti-prM Ab cross-reacted with BHK-21 or A549 cells and recognized self-Ags such as heat shock protein 60. In summary, a novel mechanism of anti-prM Ab-mediated enhancement on dengue virus infection was found to be mediated by dual specific binding to dengue virion and to target cells, in addition to the traditional enhancement on FcR-bearing cells.

Citing Articles

A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures.

Kuhn R, Barrett A, DeSilva A, Harris E, Kramer L, Montgomery R J Infect Dis. 2023; 228(Suppl 6):S398-S413.

PMID: 37849402 PMC: 10582523. DOI: 10.1093/infdis/jiad193.


A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines.

Soloman Singh R, Singh A, Masih G, Batra G, Sharma A, Joshi R Heliyon. 2023; 9(6):e16813.

PMID: 37303517 PMC: 10245239. DOI: 10.1016/j.heliyon.2023.e16813.


Innate and adaptive immune evasion by dengue virus.

Lee M, Voon G, Lim H, Chua M, Poh C Front Cell Infect Microbiol. 2022; 12:1004608.

PMID: 36189361 PMC: 9523788. DOI: 10.3389/fcimb.2022.1004608.


Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.

Cheng Y, Chao C, Lai Y, Hsieh K, Wang J, Wan S Front Immunol. 2022; 13:941923.

PMID: 36045680 PMC: 9420930. DOI: 10.3389/fimmu.2022.941923.


Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response.

Fernandes-Santos C, de Azeredo E Viruses. 2022; 14(5).

PMID: 35632732 PMC: 9147118. DOI: 10.3390/v14050992.